Industry Focus
Healthcare: After Spinning Off Its Fastest-Growing Drugs, What's Next For Biogen?
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:22:14
- Mais informações
Informações:
Sinopse
Competitors make headway against Teva Pharmaceutical's top-seller, and Biogen's hemophilia drugs become Bioverativ. Here's what you should know.
